Last updated on November 2017

Type 2 diabetes and kidney disease


Brief description of study

Type 2 diabetes and kidney disease

Detailed Study Description

The purpose of the study is to find out if canagliflozin has a kidney and cardiovascular protective effect to reduce the progression of diabetic kidney and heart disease compared to placebo.

Clinical Study Identifier: TX7568

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Stephanie Hanzl

Northeast Clinical Research Center, LLC.
Bethlehem, PA USA
  Connect »